| Jessica Marie Henry, OTD, OTR/L | |
|
1270 Turner St, Clearwater, FL 33756-5921 | |
| (931) 561-7648 | |
| Not Available |
| Full Name | Jessica Marie Henry |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1270 Turner St, Clearwater, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104106616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT15877 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Marie Henry, OTD, OTR/L 2597 Countryside Blvd Apt 211, Clearwater, FL 33761-3566 Ph: (931) 561-7648 | Jessica Marie Henry, OTD, OTR/L 1270 Turner St, Clearwater, FL 33756-5921 Ph: (931) 561-7648 |
News Archive
BioTuesday Publishing Corporation, a division of Kilmer Lucas Inc., announced today its launch of an independent business and investing news blog, BioTuesday.ca, that will focus on exciting companies and technologies in the Canadian healthcare sector.
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
The Sleep Research Society has selected three outstanding sleep and circadian scientists as recipients of the 2020 Sleep Research Society awards, which recognize excellence in sleep and circadian research.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended September 30, 2009 of $549,000, or $0.07 per fully diluted share, compared to a loss from continuing operations of $603,000, or $0.08 per fully diluted share, for the quarter ended September 30, 2008. Included in the results for the fiscal quarter ended September 30, 2009 is the pre-tax gain of $2,342,000 from the September 2009 sale of three home health businesses.
› Verified 5 days ago
Michelle Auer, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 601 Cleveland St Ste 525, Clearwater, FL 33755 Phone: 800-420-1036 | |
Kelsey Lauren Griffiths, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1270 Turner St, Clearwater, FL 33756 Phone: 727-443-7639 | |
Mrs. Penelope Marie Russell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-462-7086 Fax: 727-298-6056 | |
Mrs. Josee Scully, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 430 Morton Plant St Ste 101, Clearwater, FL 33756 Phone: 727-462-7237 | |
Terrance Wilder, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 420 Bay Ave, Clearwater, FL 33756 Phone: 727-445-4795 | |
Kathryn Hamlin-pacheco, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2753 State Road 580 Ste 111, Clearwater, FL 33761 Phone: 727-724-5437 |